Pakistan Institute of Medical Sciences, Islamabad

HEMATOLOGY & BONE MARROW TRANSPLANT

Pediatric Oncology

CHILDREN’S HOSPITAL

Overview

The Department of Pediatric Hematology, Oncology and Bone Marrow Transplant at Children’s Hospital, Pakistan Institute of Medical Sciences (PIMS), Islamabad, is a specialized tertiary-care centre dedicated to the diagnosis, treatment and comprehensive management of childhood cancers and hematological disorders. It was the first centre in government sector to start treating childhood malignancies.

The department provides multidisciplinary care for children with leukemias, lymphomas, solid tumours, thalassemia and other blood disorders and around 450-500 transfusions per month. Its facilities include a 14-bed inpatient oncology ward, a six-bed day-care chemotherapy unit and dedicated outpatient services. Managing approximately 120–130 new paediatric cancer cases annually, the department integrates clinical expertise across paediatric oncology, surgery, radiology, histopathology, hematology and other relevant specialties.

The Bone Marrow Transplant Centre, established in 2009, became an integral hospital service in 2017 and has performed approximately 100 transplants, with a reported success rate of 90%. Through specialized treatment, multidisciplinary collaboration, clinical research and postgraduate training, the department is committed to advancing evidence-based care and improving outcomes for children and adolescents with cancer and blood disorders across Pakistan.

Services

  • Treating all types of pediatric cancers, including leukemias, lymphomas and solid tumours.
  • Offering fully matched sibling donor BMT for thalassemia major and aplastic anaemia patients.
  • Management of registered thalassemia, hemophilia and other bleeding-disorder patients with regular blood transfusion, chelation therapy, and supportive care.

Facilities

  • Separate OPDs for Oncology, Blood Disorders and Bone Marrow Transplant (BMT).
  • 14-bed inpatient oncology ward.
  • Six-bed day-care chemotherapy unit.

Faculty & key staff

Prof. Dr. Nuzhat Yasmeen

Head of Department

MBBS, DCH, MCPS, FCPS, PGPN, CHPE

Dr. Ruqayya Manzoor

Assistant Professor

MBBS, MCPS, FCPS

Dr. Hijab Shaheen

Assistant Professor

MBBS, FCPS Paed., FCPS (Haem.)

Dr. Ana Farooq

Fellow, Medical Officer

Dr. Ubaid-Ullah Arshad

Medical Officer

Dr. Tazeen Anwar

Medical Officer

Dr. Riaz Khan

Medical Officer

Dr. Ameer Badshah

Medical Officer

Dr. Uzma Bari

Medical Officer

Teaching & training

  • FCPS: Pediatric Hematology & Oncology.
  • MD: Pediatric Hematology & Oncology.

OPD & patient information

OPD timings

  • Daily OPD: 8:00 AM–1:00 PM.
  • Friday: 8:00 AM–12:00 noon.

OT-day referrals

On OT days, care is available for referred patients only.

Location & contact

  • Oncology OPD: first floor, Children’s Hospital building.
  • Thalassemia Centre: ground floor, Children’s Hospital building.
  • BMT OPD: ground floor, Children’s Hospital building.

Telephone: 051-90714250

Collaboration & quality improvement

  • St. Jude Global PrOFILE Initiative: Completed the Pediatric Oncology Facility Integrated Local Evaluation (PrOFILE) initiative from June 2025 to April 2026.
  • PANORAMA Initiative: Completed departmental participation in the PANORAMA initiative from June 2025 to April 2026.
  • Evidence-Based Nursing: Completed an evidence-based nursing project in collaboration with St. Jude Global USA.

These institutional assessment and improvement-planning frameworks support the evaluation of pediatric oncology service delivery, identification of service gaps, and prioritization of locally relevant quality-improvement activities.

Multidisciplinary clinical collaboration

  • Virtual Multidisciplinary Team Meetings: Participation in virtual multidisciplinary team (vMDT) discussions and collaborative case reviews involving St. Jude Global and relevant clinical specialists.
  • Interdepartmental Collaboration: Multidisciplinary coordination with Paediatric Surgery, Radiology and other relevant specialties to support diagnostic evaluation, treatment planning and coordinated patient management.
  • Additional Collaborative Programmes: Participation in activities identified by the department as POEM- and NOORI-related multidisciplinary initiatives.

Cancer registration

  • National Pediatric Cancer Registration: Participation in activities associated with the Pakistan Society of Pediatric Oncology (PSPO) National Pediatric Cancer Registration Program, supporting standardised childhood cancer registration, research and the development of a stronger national evidence base from January 2026.
  • Cancer Registry Collaboration: Engagement in cancer registration and data-strengthening activities associated with the Punjab Cancer Registry from 2025.

Research & academic contributions

  • Clinical Research: Department-reported clinical research and protocol-based studies involving childhood malignancies, including Wilms tumour (WT), acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), classical Hodgkin lymphoma (cHL) and non-Hodgkin lymphoma (NHL) in Collaboration with PSPO.
  • Scientific Presentations: Departmental participation in scientific presentations at SIOP, ASCO, PPA and PSPO conferences.

The department reports six research publications in 2026 in national and international journals, including Neuro-oncology Pediatrics, Journal of Psychosocial Oncology, ecancer-medicine, Onco-Daily Medicine, and the Journal of University College of Medicine and Dentistry.